Loading...
Anti-oral Squamous Cell Carcinoma Effects of a Potent TAZ Inhibitor AR-42
Oral squamous cell carcinoma (OSCC) is one of the most common malignancies worldwide. Although great progress has been made in diagnosis and treatment strategies in recent years, the 5-year survival rate of OSCC patients is still disappointingly low. Hence, there is still an unmet medical need for s...
Saved in:
| Published in: | J Cancer |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Ivyspring International Publisher
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6930442/ https://ncbi.nlm.nih.gov/pubmed/31897232 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.32436 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|